Clexane 20mg, 40mg, 60mg, 80mg, 100mg Solution for injection

Clexane 20mg, 40mg, 60mg, 80mg, 100mg Solution for injection

S4
PDF Leaflet Revision Date: 13 October 2023

API: Enoxaparin | Company: Sanofi-Aventis

Clinical Summary

Quick overview from the medicine insert

Indication

Prevention and treatment of venous thromboembolism.

Dosage (summary)

20 mg to 100 mg SC once daily, depending on indication.

Special Populations

  • Elderly
  • Renal impairment
  • Hepatic impairment

Pregnancy & Breastfeeding

Use only if clearly needed; breastfeeding not recommended.

Key Drug Interactions

  • NSAIDs
  • Thrombolytics
  • Antiplatelet agents

Contraindications

  • Hypersensitivity to CLEXANE
  • Active major bleeding
  • History of heparin-induced thrombocytopenia

Common side effects

  • Haemorrhage
  • Thrombocytopenia
  • Injection site reactions

Counselling Points

  • Monitor for signs of bleeding
  • Avoid NSAIDs
  • Report any unusual symptoms immediately

Serious warnings

  • Risk of spinal/epidural haematoma
  • Increased bleeding risk in elderly
Important Disclaimer

The Clexane 20mg, 40mg, 60mg, 80mg, 100mg Solution for injection professional information leaflet below is the property of Sanofi-Aventis and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>

Healthcare Professionals Only

This content is for registered healthcare professionals

Sign in or create a free account to read the full package insert.

Free for HPCSA-registered professionals. Powered by Medinsert.

Successfully Stashed! 💊

This package insert has been safely stored in your digital medical cabinet. No prescription needed to view it later!

View My Favourites